Fujimoto et al. BMC Cancer 2010, 10:443 http://www.biomedcentral.com/1471-2407/10/443 mediated EGFR activation promotes cell migration. Oncol Rep 2006, 15:889-893. 21. Tantivejkul K, Lodberg DR, Pienta JK, et al: PAR1-mediated NFkappaB activation promotes survival of prostate cancer cells through a Bcl-xL- dependent mechanism. J Cell Biochem 2005, 96:641-652. 22. Fujimoto D, Hirono Y, Goi T, Katayama K, Yamaguchi A: Prognostic value of protease-activated receptor-1 (PAR-1) and matrix metalloproteinase-1 (MMP-1) in gastric cancer. Anticancer Res 2008, 28:847-854. 23. De Wever O, Nguyen QD, Van Hoorde L, Bracke M, Bruyneel E, Gespach C, Mareel M: Tenascin-C and SF/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac. FASEB J 2004, 18:1016-1018. 24. Ahn HS, Foster C, Boykow G, Stamford A, Manna M, Granziano M: Inhibition of cellular action of thrombin by N3-cyclopropyl-7-{[4-(1-methlethyl-) phenyl]methyl}-7H-pyrrolo[3,2-f] quinazoline-1,3-diamine (SCH79797), a nonpeptide thrombin receptor antagonist. Biochem Pharmacol 2000, 60:1425-1434. 25. Natarajan K, Singh S, Bruke TR Jr, Grunberger D, Aggarwal BB: Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. Proc Natl Acad Sci USA 1996, 93:9090-9095. 26. Mann KG, Brummel K, Butenas S: What is all that thrombin for? J Thromb Haemost 2003, 1:1504-1524, Review. 27. Kawabata A, Saifeddine M, Al-Ani B, Leblond L, Hollenberg MD: Evaluation of proteinase-activated receptor-1 (PAR1) agonists and antagonists using a cultured cell receptor desensitization assay: activation of PAR2 by PAR1-targeted ligands. J Pharmacol Exp Ther 1999, 288:358-370. 28. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaroonson SA, Kozlowski JM, McEwan RN: A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987, 47:3239-3245. 29. Kuliopulos A, Covic L, Seeley SK, Sheridan PJ, Helin J, Costello CE: Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy. Biochemistry 1999, 38:4572-4585. 30. Ishii K, Hein L, Kobilka B, Coughlin SR: Kinetics of thrombin receptor cleavage on intact cells-relation to signaling. J Biol Chem 1993, 268:9780-9786. 31. Vouret-Craviari V, Van Obberghen-Schilling E, Scimeca JC, Van Obberghen E, Pouysségur J: Differential activation of p44mapk (ERK1) by alpha- thrombin and thrombin-receptor peptide agonist. Biochem J 1993, 289:209-214. 32. Hollenberg MD, Mokashi M, Leblond L, DiMaio J: Synergistic actions of a thrombin-derived synthetic peptide and a thrombin receptor-activating peptide in stimulating fibroblasts mitogenesis. J Cell Physiol 1996, 169:491-496. 33. Mari B, Imbert V, Auberger P, et al: Thrombin and thrombin receptor agonist peptide induce early events of T cell activation and synergize with TCR cross-linking for CD69 expression and interleukin 2 production. J Biol Chem 1994, 269:8517-23. 34. Swindle CS, Tran KT, Johnson TD, Banerjee P, Mayes AM, Griffith L, Wells A: Epidermal growth factor (EGF)-like repeats of human Tenascin-C a ligands for EGF receptor. J Cell Biol 2001, 154:459-468. 35. Ohno Y, Izumi M, Yoshioka K, Ohori M, Yonou H, Tachibana M: Prognostic significance of tenascin-C expression in clear cell renal cell carcinoma. Oncol Rep 2008, 20:511-516, 2008. 36. Maschler S, Grunert S, Danielopol A, Beug H, Wirl G: Enhanced tenascin-C expression and matrix deposition during Ras/TGF-beta-induced progression of mammary tumor cells. Oncogene 2004, 23:3622-3633. 37. Emoto K, Yamada Y, Nakajima Y, et al: Annexin II overexpression correlates with stromal tenascin-C overexpression: a prognostic marker in colorectal carcinoma. Cancer 2001, 92:1419-1426. 38. Orend G, Chiquet-Ehrismann R: Teanscin-C induced signaling in cancer. Cancer Lett 2006, 244:143-163. Pre-publication history The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2407/10/443/prepub doi:10.1186/1471-2407-10-443 Cite this article as: Fujimoto et al.: The activation of Proteinase- Activated Receptor-1 (PAR1) mediates gastric cancer cell proliferation and invasion. BMC Cancer 2010 10:443. Page 14 of 14 Submit your next manuscript to BioMed Central and take full advantage of: • Convenient online submission • Thorough peer review • No space constraints or color ﬁgure charges • Immediate publication on acceptance • Inclusion in PubMed, CAS, Scopus and Google Scholar • Research which is freely available for redistribution Submit your manuscript at www.biomedcentral.com/submit